Loading company…
Vedantra Pharmaceuticals develops nanotechnology-based vaccines for infectious diseases and cancer.
Founded in 2011, Vedantra Pharmaceuticals develops vaccines for infectious diseases and cancer using nanotechnology-based approaches. The company is based in Massachusetts, US, and has reached Series B.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in